Hollie Jackson

Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

Katherine K. Matthay, Alekist Quach, John P. Huberty et al. · Journal of Clinical Oncology · 2009 · 118 citations · Full text

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma

Denah R. Taggart, Myo Han, Alekist Quach et al. · Journal of Clinical Oncology · 2009 · 100 citations · Full text

131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

Gregory A. Yanik, Judith G. Villablanca, John M. Maris et al. · Biology of Blood and Marrow Transplantation · 2015 · 93 citations · Full text

Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group

Judith G. Villablanca, Wendy B. London, Arlene Naranjo et al. · Clinical Cancer Research · 2011 · 92 citations · Full text

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium

Barry J. Maurer, Min H. Kang, Judith G. Villablanca et al. · Pediatric Blood & Cancer · 2013 · 86 citations · Full text